Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Innohep 4,500 IU Solution for Injection - PA0046/060/007
- Phyllocontin Continus 225mg Prolonged Release Tablets - PA1688/008/001
- RoActemra 20mg/ml Concentrate for Solution for Infusion - EU/1/08/492/001-006
- Tevanate Once Weekly 70mg Tablets - PA0749/016/001
The following shortages have been resolved and supply has resumed to the Irish market:
- Co-Aprovel Film Coated Tablets 150/12.5mg - EU/1/98/086/012
- Co-Aprovel Film Coated Tablets 300/12.5mg - EU/1/98/086/017
- Depo-Provera 150mg/ml Suspension for Injection - PA0822/124/001
- Efexor XL 37.5mg Prolonged Release Capsules - PA0822/072/001
- Lercanidipine Clonmel 20mg Film Coated Tablets - PA0126/187/002
- Prevymis 240mg Film Coated tablets - EU/1/17/1245/001
- RoActemra 162mg Solution for Injection in Pre Filled Pen - EU/1/08/492/009-10
- RoActemra 162mg Solution for Injection in Pre Filled Syringe - EU/1/08/492/007
- Zofran 4mg/2ml Solution for Injection or Infusion - PA0896/036/001
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.